Both in R&D — Physical & Biological Sciences
Absci vs Incyte Genomics
Over the past year ABSI returned +143.3% and INCY returned +17.5%; their daily moves had a correlation of 0.22.
ABSI +143.3% INCY +17.5%Growth of $1, one year, split-adjusted
| Metric | ABSI | INCY |
|---|---|---|
| Price | $10.00 | $119.34 |
| Market cap | $1.72B | $24.33B |
| Today | −10.15% | −0.87% |
| 1 month | −9.7% | +3.5% |
| 6 months | +77.9% | +22.9% |
| Year to date | +186.5% | +20.8% |
| 1 year | +144.5% | +28.9% |
| Revenue growth (YoY) | −46.4% | +14.0% |
| Gross margin | 100.0% | 93.0% |
| Net margin | −10443.4% | −50.4% |
| P/E (TTM) | — | 60.3× |
| Price / sales | 1,099.4× | 4.0× |
| Net cash | $201.0M | $3.82B |
| Dividend yield | — | — |
| Volatility (60d) | 98.8% | 26.9% |
| Short % of float | 31.0% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).